Cargando…
Hepatocellular carcinoma recurrence after liver transplantation: Risk factors, screening and clinical presentation
Liver transplantation is the best treatment option for cirrhotic patients with early-stage hepatocellular carcinoma, but it faces the problem of scarcity of donors and the risk of tumor recurrence, which affects between 15% and 20% of the cases, despite the use of restrictive criteria. The risk of r...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447422/ https://www.ncbi.nlm.nih.gov/pubmed/30967904 http://dx.doi.org/10.4254/wjh.v11.i3.261 |